Surveillance of suspected poliomyelitis in Albania, 1980-1995: Suggestion of increased risk of vaccine associated poliomyelitis

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 940-948

  Diamanti, E ^a   Ibrahimi, B ^a   Tafaj, F ^a   Mezini, E ^a   Dodbiba, A ^a   Dobi, V ^a   Catone, S ^b   Genovese, D ^b   Simeoni, P ^b   Fiore, L ^b  

^a Institute of Public Health   (Albania)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AFP; Mutation; Paralysis; Polio; Surveillance

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ALBANIA; ANTIBODY BLOOD LEVEL; ARTICLE; DRUG EFFICACY; DRUG INDUCED DISEASE; FECES ANALYSIS; HUMAN; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PARALYSIS; PHENOTYPE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PURIFICATION;

EID: 0032078711     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)80025-X     Document Type: Article

References (33)

1. 1 Melnick, J.L. Recent developments in the worldwide control of poliomyelitis. In: Control of Virus Disease (Eds Kurstak, E. and Maruryk, E.). Marcel Dekker, New York, 1984, pp. 3-31.
2. 2 Sabin, A.B. Strategies for elimination of poliomyelitis in different parts of world with use of oral poliovirus vaccine. Rev. Infect. Dis. 1984, 6(Suppl. 2), S391-S396.
3. 3 EPI/PAHO. Strategies for the certification of the eradication of wild poliovirus transmission in the Americas. Bulletin of PAHO 1993, 27, 287-296.
4. 4 Hull, H.F., Ward, N.A., Hull, B.P., Milstien, J.B. and de Quadros, C.A. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994, 343, 1331-1337.
5. 5 Patriarca, P.A., Sutter, R.W. and Oostvogel, P.M. Outbreaks of paralytic poliomyelitis, 1976 1995. J. Infect. Dis. 1997, 175(Suppl. 1), S165-S172.
6. 6 World Health Organization. Progress towards poliomyelitis eradication. Wkly Epidemiol. Rec. 1996, 71, 189-194.
7. 7 Oblapenko, G. and Sutter, R.W. Status of poliomyelitis eradication in Europe and in the Central Asian Republics of the former Soviet Union. J. Infect. Dis. 1997, 175(Suppl. 1), S76-S81.
8. 8 World Health Organization. Global eradication of poliomyelitis by the year 2000. Wkly Epidemiol. Rec. 1988, 63, 161-162.
9. 9 Wright, P.F., Kim-Farley, R.J., de Quadros, C.A., Robertson, S.E., Scott, R.M., Ward, N.A. and Henderson, R.H. Strategies for the global eradication of poliomyelitis by the year 2000. N. Engl. J. Med. 1991, 325, 1774-1779.
10. 10 World Health Organization. The Initiative for the Global Eradication of Poliomyelitis: A Guide for Clinicians. WHO/EPI/ POLIO/93-2, Geneva, Switzerland, 1993.
11. 11 World Health Organization. Field Guide for Supplementary Activities Aimed at Achieving Polio Eradication. WHO/EPI/ POLIO/95-1, Geneva, Switzerland, 1995, pp. 19-43.
12. 12 Kew, O.M., Nottay, B.K., Hatch, M.H., Nakano, J.H. and Obijesky, J.F. Multiple genetic changes can occur in the oral poliovaccine upon replication in humans. J. Gen. Virol. 1981, 56, 337-347.
13. 13 World Health Organization. Report informal meetings 1979-1980. Identification of the origin of poliovirus isolates. Lancet 1981, 2, 968-970.
14. 14 Minor, P.D., John, A., Ferguson, M. and Icenogle, J.P. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J. Gen. Virol. 1986, 67, 693-706.
15. 15 Minor, P.D. and Dunn, G. The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J. Gen. Virol. 1988, 69, 1091-1096.
16. 16 Equestre, M., Genovese, D., Cavalieri, F., Fiore, L., Santoro, R. and Perez-Bercoff, R. Identification of a consistent pattern of mutations in neurovirulent variants derived from the Sabin vaccine strain of poliovirus type 2. J. Virol. 1991, 65, 2707-2710.
17. 17 Weekly Epidemiological Record. Poliomyelitis outbreak. Albania 1996 39(71), 213-295.
18. 18 Diamanti, E., Ibrahimi, B., Sharofi, F., Koco, L., Dodbiba, A. and Dobi V. Poliomyelitis in Albania. Symposium on the Poliomyelitis, Tirana, 11 April 1995.
19. 19 Diamanti, E., Ibrahimi, B. and Koco, L. The efficacy of trivalent oral poliovaccine in Albania. Bulletin of the Public Health Institute of Tirana 1983, 2, 18-26.
20. 20 Diamanti, E., Ibrahimi, B., Dobi, V. and Dodbiba, A. The Immunization Status against Poliomyelitis in Albania, 1986-1990 Years. Bulletin of the University of Tirana, Serial Medical Science, Tirana, 1996.
21. 21 Squarcione, S., Germinario, C., Iandolo, E., Lo Caputo, S., Bergamini, F., Profeta, M.L., Greco, D., Quarto, M. and Barbuti, S. Seroimmunity to poliomyelitis in an Albanian immigrant population. Vaccine 1992, 10, 853-856.
22. 22 Offerhaus, L. Albania: a plundered country. Lancet 1991, 338, 44-45.
23. 23 World Health Organization. Expanded Programme on Immunization. Manual for the Virological Investigation of Poliomyelitis. WHO/EPI/CDC/POLIO/90.1, Geneva, Switzerland, 1990.
24. 24 Melnick, J.L., Rennick, V., Hampil, B., Schmidt, N.J. and Ho, H.H. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull. World Health Organ. 1973, 48, 263-268.
25. 25 Sabin, A.B. Reproductive capacity of polioviruses of diverse origin at various temperatures. In: Perspectives in Virology 2 (Ed. Pollard, S.R.). Burgess, Minneapolis MN, 1961, pp. 90-110.
26. 26 Balanant, J., Guillot, S., Candrea, A., Delpeyroux, F. and Crainic, R. The natural genomic variability of poliovirus analyzed by a restriction fragment lenght polymorphism assay. Virology 1991, 184, 645-654.
27. 27 Oberhofer, T.R., Brown, G.C. and Monto, A.S. Seroimmunity to poliomyelitis in an American community. Am. J. Epidemiol. 1975, 101, 333-339.
28. 28 Kew, O.M., Mulders, M.N., Lipskaya, G.Y., Da Silva, E.E. and Pallansch, M.A. Molecular epidemiology of poliovirus. Seminars in Virology 1995, 6, 401-414.
29. 29 Pollard, S.R., Dunn, G., Cammack, N., Minor, P.D. and Almond, J.W. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J. Virol. 1989, 63, 4949-4951.
30. 30 Friedrich, F., Filippis, A.M., Ferreira, F.C., Schatzmayr, H.G. and Da-Silva, E.E. Genomic characterization of type 2 polio-viruses isolated from vaccine-associated cases in Brazil, Braz. J. Med. Biol. Res. 1995, 28, 733-742.
31. 31 Bateman, D.E., Erlington, G., Kennedy, P. and Saunders, M. Vaccine related poliomyelitis in non-immunized relatives and household contacts. BMJ 1987, 294, 170-171.
32. 32 Drozdov, S.G., Shirman, G.A., Ashmarina, E.E. and Knjazeva, T.V. The dynamic excretion of three types vaccine polio-viruses in immunization children and their contacts: the characteristics of isolates. The Oral Poliomyelitis Vaccine 1961, 5, 175-183.
33. 33 Crainic, R., Furione, M., Otelea, D., Guillot, S., Balanant, J., Aubert-Combiescu, A., Combiescu, M. and Candrea, A. Natural evolution of oral vaccine poliovirus strains. In: Measles and Poliomyelitis (Ed Kurstak, E.). Springer-Verlag, Austria, 1993, pp. 339-358.